Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 19/20 | 0.67 |
| ▸ | HCRTR2 | O43614 | 19/20 | 0.67 |
| ▸ | RBP4 | P02753 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6923980 | 0.81 | HCRTR2 (1.00) | HCRTR1HCRTR2 | |
| SCHEMBL1673053 | 0.75 | HCRTR2 (0.55) | HCRTR1HCRTR2 | |
| SCHEMBL13732925 | 0.72 | HCRTR1 (0.68) | HCRTR1HCRTR2 | |
| SCHEMBL1671065 | 0.72 | HCRTR1 (0.66) | HCRTR1HCRTR2 | |
| SCHEMBL1673117 | 0.72 | HCRTR1 (0.67) | HCRTR1HCRTR2 | |
| SCHEMBL1673097 | 0.70 | HCRTR1 (0.68) | HCRTR1HCRTR2 | |
| SCHEMBL1671556 | 0.68 | HCRTR1 (0.64) | HCRTR1HCRTR2 | |
| SCHEMBL1673008 | 0.68 | HCRTR1 (0.64) | HCRTR1HCRTR2 | |
| SCHEMBL1672518 | 0.68 | HCRTR2 (1.00) | HCRTR1HCRTR2 | |
| SCHEMBL11909955 | 0.67 | HCRTR2 (0.66) | HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012145581-A1 | DISUBSTITUTED OCTAHY-DROPYRROLO [3,4-C] PYRROLES AS OREXIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2012-10-26 | — | — | WO | disclosed |
| EP-2491038-A1 | DISUBSTITUTED OCTAHY - DROPYRROLO [3,4-C]PYRROLES AS OREXIN RECEPTOR MODULATORS | Janssen Pharmaceutica N.V. (BE) | 2012-08-29 | — | — | EP | disclosed |
| WO-2011050198-A1 | DISUBSTITUTED OCTAHY - DROPYRROLO [3,4-C] PYRROLES AS OREXIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-04-28 | — | — | WO | disclosed |